Immediate Impact
28 standout
Citing Papers
Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS)
2025 Standout
Radiopharmaceuticals and their applications in medicine
2025 Standout
Works of Ailsa Langford being referenced
ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer treated with enzalutamide (ANZUP 1901)
2021
Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR)
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ailsa Langford | 144 | 44 | 63 | 6 | 193 | |
| Derek Price | 96 | 68 | 19 | 7 | 136 | |
| Per-Henrik Zahl | 48 | 10 | 155 | 6 | 282 | |
| Thomas Gey | 260 | 16 | 24 | 7 | 284 | |
| M. M. Eberl | 27 | 26 | 100 | 7 | 281 | |
| Annuska Schoorlemmer | 80 | 14 | 93 | 8 | 160 | |
| Ph. Astoul | 252 | 19 | 20 | 5 | 270 | |
| Cristiana Pascucci | 174 | 30 | 20 | 7 | 226 | |
| Lavinia Tan | 97 | 22 | 80 | 12 | 184 | |
| Craig Womeldorph | 81 | 16 | 136 | 9 | 232 | |
| Clive Hayward | 38 | 18 | 24 | 6 | 175 |
All Works
Loading papers...